CLINICAL TRIALS

Androgenetic Alopecia
(Hair Loss)

Androgenetic alopecia is hair loss (at scalp level) caused by the thinning of hair follicles.

It is very common in men between the ages of 19 and 65. There are currently two products available on the market and approved by the FDA and Health Canada to treat this condition (Minoxidil as topical treatment and finasteride orally to be taken daily).

Unfortunately, neither of them is completely effective.

Triple Hair has therefore developed a new, more effective treatment regimen involving a combination of three drugs (all of them already approved by Health Canada with the same dosages) that causes fewer side effects due to its innovative format.

The Effectiveness of Triple Hair

Triple Hair has conducted a proof of concept designed to evaluate the effectiveness of triple therapy in stopping hair loss and augmenting hair thickness, pigmentation and number of hair follicles in comparison to what is currently on the market.

Triple Hair TH07

Since 2014, several clinical trials were conducted in order to measure the effectiveness of the combination of three drugs.

For this proof of concept, Triple Hair has developed a new treatment regimen involving a combination of two health products already approved by Health Canada and deemed to be more effective and carry fewer side effects owing to its topical form.

This video is a testimonial from two patients who participated in a clinical trial that lasted six months.

Triple Hair TH16

Since 2014, several clinical trials were conducted to evaluate the efficiency of the proprietary blend combination in increasing the thickness, pigmentation and number of hair follicles.

This video is a testimonial from a patient who participated in a clinical trial that lasted six months.

Recent Results

"Got some great results from start to finish over the first of the 6 months. Starting off at 22 years old, losing some of your hair...  having that hair was a big thing for me."

Image

"I've been on the prescribed product for 3 years now. It works very well for me. I personally have seen just positive effects and a lot of regrowth in the last 3 years."

Image

"It was working pretty well. A lot of people noticed there was growth of my hair... within a few months there was a difference. I would recommend the product to other people."

Image

CLINICAL TRIAL RESULTS

Triple Hair has conducted several proof of concepts on TH16 with its different
concentrate to confirm its superiority to Minoxodil.

Triple Hair also conducted a successful proof of concept on TH07 with 100% hair regrowth and the results were confirmed in a longer study which was later presented to the FDA and Health Canada.

 

Image

TH07 (Prescription Product)

The goal of our clinical trial was to prove the efficiency of the synergy of the three drugs in preventing hair loss and contributing to hair regrowth as compared to its components used as monotherapies.

The Study began in November 2014 with the first group of participants with the overall goal of measuring the effectiveness of the different products.

The pictures BEFORE and AFTER highlights the results and effectiveness of TH07 on the participants who used the product over the six (6) months duration of the Study. Pictures representing their scalp (parietal frontal or parietal mid- vertex/crown areas) were taken at the beginning of the Study and after six (6) months.

 BeforeAfter TH07 Third

beforeafter nathan

beforeafter raymond

TH16 (Natural Product)

The goal of our clinical trial was to prove the efficiency of the synergy of the two natural health products in preventing hair loss and increasing the number, thickness and pigmentation of hair.

The pictures BEFORE and AFTER highlights the results and effectiveness of TH16 on the participants who used the product over the six (6) months duration of the Study. Pictures representing their scalp (parietal frontal or parietal mid- vertex/crown areas) were taken at the beginning of the Study and after six (6) months.

 

BeforeAfter TH16 AdrienBeforeAfter TH16 01BeforeAfter TH16 02BeforeAfter TH16 03

 

WANT TO BECOME AN INVESTOR,
TRY OUR PRODUCTS OR TAKE
PART IN OUR NEXT CLINICAL TRIAL?

We invite you to sign up for our email alerts and welcome any questions you may have.